High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$119K
$119,311
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to CoverΔOwn -14.4%
2026-03-18
$55,122
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to CoverΔOwn -14.4%
|
2026-03-18 | $55,122 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-18
$4,419
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-18 | $4,419 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-18
$986
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-18 | $986 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-17
$33,820
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-17 | $33,820 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-17
$24,965
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-17 | $24,965 | S | Form 4 |